Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Conditions
Advanced Esophageal Squamous Cell Carcinoma · Advanced Renal Cell Carcinoma · Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 · Clinical Stage IIB Cutaneous Melanoma AJCC v8 · Clinical Stage IIC Cutaneous Melanoma AJCC v8 · Clinical Stage III Cutaneous Melanoma AJCC v8 · Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 · Esophageal Carcinoma · Gastroesophageal Junction Adenocarcinoma · Hepatocellular Carcinoma · Locally Advanced Urothelial Carcinoma · Lung Non-Small Cell Carcinoma · Malignant Solid Neoplasm · Metastatic Colorectal Carcinoma · Metastatic Cutaneous Melanoma · Metastatic Esophageal Squamous Cell Carcinoma · Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Urothelial Carcinoma · Recurrent Esophageal Squamous Cell Carcinoma · Recurrent Head and Neck Squamous Cell Carcinoma · Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v8 · Stage IV Colorectal Cancer AJCC v8 · Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 · Stage IV Renal Cell Cancer AJCC v8 · Unresectable Cutaneous Melanoma · Unresectable Esophageal Squamous Cell Carcinoma · Urothelial Carcinoma · Unresectable Urothelial Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic in Florida, Jacksonville, Florida, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015Contact: Principal Investigator (Roxana S. Dronca, M.D.)
Study leads
Roxana S. Dronca, M.D.
Principal Investigator
Mayo Clinic